Preimplantation genetic screening: Back to the future

Human Reproduction

Volumn 29, Issue 9, 2014, Pages 1846-1850

  Mastenbroek, Sebastiaan ^a   Repping, Sjoerd ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

aneuploidy; efficacy; IVF ICSI; PGS; randomized controlled trials

Indexed keywords

BLASTOCYST; BLASTOMA; CHROMOSOME; CLINICAL EVALUATION; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; DIAGNOSTIC ACCURACY; EMBRYO TRANSFER; EXPERIMENTAL THERAPY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENETIC SCREENING; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; LIVE BIRTH; MALPRACTICE; MEDICAL ETHICS; META ANALYSIS (TOPIC); MONEY; MOSAICISM; POLAR BODY; PREDICTIVE VALUE; PREGNANCY; PREGNANCY RATE; PREIMPLANTATION EMBRYO; PREIMPLANTATION GENETIC SCREENING; PRENATAL DIAGNOSIS; PREVALENCE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCTION; REVIEW; SUBFERTILITY; EMBRYO DEVELOPMENT; FEMALE; INFERTILITY THERAPY; PROCEDURES; STANDARDS; TRENDS;

EMBRYONIC DEVELOPMENT; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PREGNANCY; PREGNANCY RATE; PREIMPLANTATION DIAGNOSIS; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 84906084802     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu163     Document Type: Review

References (48)

1. American College of Obstetricians and Gynecologists. ACOG committee opinion No. 430: preimplantation genetic screening for aneuploidy. Obstet Gynecol 2009;113:766-767.
2. Barlow DH. The design, publication and interpretation of research in Subfertility Medicine: uncomfortable issues and challenges to be faced. Hum Reprod 2003;18:899-901. (Pubitemid 36592024)
3. Brown S. After 20 years, preimplantation genetic screening is in a new technology phase. Focus on Reproduction January 2014, pp. 14-15.
4. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, and Society for Assisted Reproductive Technology. 2010 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports, 2012.
5. Clinical Evidence from the BMJ Evidence Centre. What conclusions has Clinical Evidence drawn about what works, what doesn't based on randomised controlled trial evidence? 2014. http://clinicalevidence.bmj.com/x/set/static/ cms/efficacy-categorisations.html (31 March 2014, date last accessed).
6. Daya S. Pitfalls in the design and analysis of efficacy trials in subfertility. Hum Reprod 2003;18:1005-1009. (Pubitemid 36592042)
7. De Vos A, Van Steirteghem A. Aspects of biopsy procedures prior to preimplantation genetic diagnosis. Prenat Diagn 2001;21:767-780.
8. Dondorp W, de Wert G. Innovative reproductive technologies: risks and responsibilities. Hum Reprod 2011;26:1604-1608.
9. Forman EJ, Hong KH, Ferry KM, Tao X, Taylor D, Levy B, Treff NR, Scott RT Jr. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertil Steril 2013;100:100-107.
10. Gianaroli L, Magli MC, Ferraretti AP, Fiorentino A, Garrisi J, Munne S. Preimplantation genetic diagnosis increases the implantation rate in human in vitro fertilization by avoiding the transfer of chromosomally abnormal embryos. Fertil Steril 1997;68:1128-1131. (Pubitemid 28013382)
11. Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, Michie S, Moher D, Wager E. Reducing waste from incomplete or unusable reports of biomedical research. Lancet 2014;383:267-276.
12. Glujovsky D, Blake D, Farquhar C, Bardach A. Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev 2012;7:CD002118.
13. Gotzsche PC, Hrobjartsson A, Johansen HK, Haahr MT, Altman DG, Chan AW. Ghost authorship in industry-initiated randomised trials. PLoS Med 2007;4:e19.
14. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-926. (Pubitemid 351632017)
15. Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol 2011;64:380-382.
16. Hassold T, Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet 2001;2:280-291. (Pubitemid 33674776)
17. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. (updated September 2009), 2009. www.cochrane-handbook.org.
18. Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, Schulz KF, Tibshirani R. Increasing value and reducing waste in research design, conduct, and analysis. Lancet 2014;383:166-175.
19. Kahraman S, Bahce M, Samli H, Imirzalioglu N, Yakisn K, Cengiz G, Donmez E. Healthy births and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation failure. Hum Reprod 2000; 15:2003-2007.
20. Krumholz SD, Egilman DS, Ross JS. Study of neurontin: titrate to effect, profile of safety (STEPS) trial: a narrative account of a gabapentin seeding trial. Arch Intern Med 2011;171:1100-1107.
21. Lintsen AM, Eijkemans MJ, Hunault CC, Bouwmans CA, Hakkaart L, Habbema JD, Braat DD. Predicting ongoing pregnancy chances after IVF and ICSI: a national prospective study. Hum Reprod 2007;22: 2455-2462. (Pubitemid 47289061)
22. Macleod MR, Michie S, Roberts I, Dirnagl U, Chalmers I, Ioannidis JP, Al-Shahi Salman R, Chan AW, Glasziou P. Biomedical research: increasing value, reducing waste. Lancet 2014;383:101-104.
23. Mastenbroek S, Bossuyt PMM, Heineman MJ, Repping S, van der Veen F. Comment 1 on Staessen et al. Design and analysis of a randomized controlled trial studying preimplantation genetic screening. Hum Reprod 2005;20:2362-2363. (Pubitemid 41418534)
24. Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, Verhoeve HR, Vogel NE, Arts EG, de Vries JW, Bossuyt PM et al. In vitro fertilization with preimplantation genetic screening. N Engl J Med 2007;357:9-17. (Pubitemid 47026730)
25. Mastenbroek S, Twisk M, van der Veen F, Repping S. Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update 2011a;17:454-466.
26. Mastenbroek S, van der Veen F, Aflatoonian A, Shapiro B, Bossuyt P, Repping S. Embryo selection in IVF. Hum Reprod 2011b;26:964-966.
27. Moutou C, Goossens V, Coonen E, De Rycke M, Kokkali G, Renwick P, Sengupta SB, Vesela K, Traeger-Synodinos J. ESHRE PGD Consortium data collection XII: cycles from January to December 2009 with pregnancy follow-up to October 2010. Hum Reprod 2014;29:880-903.
28. Munne S, Magli C, Cohen J, Morton P, Sadowy S, Gianaroli L, Tucker M, Marquez C, Sable D, Ferraretti AP et al. Positive outcome after preimplantation diagnosis of aneuploidy in human embryos. Hum Reprod 1999;14:2191-2199. (Pubitemid 29425399)
29. Munne S, Sandalinas M, EscuderoT, Velilla E, Walmsley R, Sadowy S, Cohen J, Sable D. Improved implantation after preimplantation genetic diagnosis of aneuploidy. Reprod Biomed Online 2003;7:91-97. (Pubitemid 36874416)
30. Pennings G, deWert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P. ESHRE Task Force on Ethics and Law 13: the welfare of the child in medically assisted reproduction. Hum Reprod 2007;22:2585-2588. (Pubitemid 47434200)
31. Practice Committee of the Society for Assisted Reproductive Technology and Practice Committee of the American Society for Reproductive Medicine. Preimplantation genetic testing: a Practice Committee opinion. Fertil Steril 2007;88:1497-1504.
32. Psaty BM, Kronmal RA. Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: a case study based on documents from rofecoxib litigation. JAMA 2008;299:1813-1817. (Pubitemid 351549972)
33. Ross JS, Hill KP, Egilman DS, Krumholz HM. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA 2008;299:1800-1812. (Pubitemid 351549971)
34. Rubio C, Rodrigo L, Mir P, Mateu E, Peinado V, Milan M, Al-Asmar N, Campos-Galindo I, Garcia S, Simon C. Use of array comparative genomic hybridization (array-CGH) for embryo assessment: clinical results. Fertil Steril 2013;99:1044-1048.
35. Schoolcraft WB, Fragouli E, Stevens J, Munne S, Katz-Jaffe MG, Wells D. Clinical application of comprehensive chromosomal screening at the blastocyst stage. Fertil Steril 2010;94:1700-1706.
36. Schoolcraft WB, Treff NR, Stevens JM, Ferry K, Katz-Jaffe M, Scott RT Jr. Live birth outcome with trophectoderm biopsy, blastocyst vitrification, and single-nucleotide polymorphism microarray-based comprehensive chromosome screening in infertile patients. Fertil Steril 2011;96:638-640.
37. Scott RT Jr, Upham KM, Forman EJ, Hong KH, Scott KL, Taylor D, Tao X, Treff NR. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril 2013a;100:697-703.
38. Scott RT Jr, Upham KM, Forman EJ, Zhao T, Treff NR. Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil Steril 2013b;100:624-630.
39. Scriven PN, Bossuyt PM. Diagnostic accuracy: theoretical models for preimplantation genetic testing of a single nucleus using the fluorescence in situ hybridization technique. Hum Reprod 2010;25:2622-2628.
40. Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, Devroey P, Liebaers I, Van Steirteghem A. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 2004;19:2849-2858. (Pubitemid 40028958)
41. Twisk M, Mastenbroek S, van Wely M, Heineman MJ, van der Veen F, Repping S. Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database Syst Rev 2006;CD005291.
42. Vail A, Gardener E. Common statistical errors in the design and analysis of subfertility trials. Hum Reprod 2003;18:1000-1004. (Pubitemid 36592041)
43. van Echten-Arends J, Mastenbroek S, Sikkema-Raddatz B, Korevaar JC, Heineman MJ, van der V, Repping S. Chromosomal mosaicism in human preimplantation embryos: a systematic review. Hum Reprod Update 2011;17:620-627.
44. Verlinsky Y, Cieslak J, Freidine M, Ivakhnenko V, Wolf G, Kovalinskaya L, White M, Lifchez A, Kaplan B, Moise J et al. Pregnancies following pre-conception diagnosis of common aneuploidies by fluorescent in-situ hybridization. Hum Reprod 1995;10:1923-1927.
45. Website Blue Gnome. Blue Gnome 24sure Scientific Evidence. 2014. http://www.cambridgebluegnome.com/products/24sure/scientific-evidence/ (31 March 2014, date last accessed).
46. Wells D, Alfarawati S, Fragouli E. Use of comprehensive chromosomal screening for embryo assessment: microarrays and CGH. Mol Hum Reprod 2008;14:703-710.
47. Wong K, Mastenbroek S, Repping S. Cryopreservation of human embryos and its contribution to in vitro fertilization success rates. Fertil Steril (in press) 2014. http://dx.doi.org/10.1016/j.fertnstert.2014.05.027.
48. Yang Z, Liu J, Collins GS, Salem SA, Liu X, Lyle SS, PeckAC, Sills ES, Salem RD. Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet 2012;5:24.